Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In July 2024, we entered into a license agreement (the "AbbVie License Agreement") with AbbVie, pursuant to which we have been granted a license to research, develop and commercialize certain CFTR compounds.”
FILING10-K0001628280-26-012996cik 0002036042
“In December 2019, we entered into a license agreement, which has been subsequently amended (as amended, the "Sanofi License Agreement"), with Sanofi, pursuant to which we have been granted an exclusive, worldwide, sublicensable, royalty-bearing license to develop and commercialize products using the licensed compounds and know-how for CFTR modulator therapies.”
FILING10-K0001628280-26-012996cik 0002036042
“In particular, certain of the licensed patents and other intellectual property rights were developed by or on behalf of Galapagos and are sublicensed to us subject to the terms of the second amended and restated collaboration agreement between Galapagos and AbbVie in October 2018 (the "Galapagos License Agreement"), as amended by a side letter between Galapagos and AbbVie in July 2024.”
FILING10-K0001628280-26-012996cik 0002036042
“As initial consideration for CFF's grant of, and forbearance from exercising, its rights under the CFFT-Genzyme Agreement, we issued CFF 300,300 shares of our Series Seed preferred stock.”
FILING10-K0001628280-26-012996cik 0002036042
Watchlist prices, news filtered to it, and its next report on your desk.
Sionna Therapeutics, Inc. has 4 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Sionna Therapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Sionna Therapeutics, Inc.. Customers appear here when Sionna Therapeutics, Inc. names them, or when a company names Sionna Therapeutics, Inc. as a supplier in its own annual report.
Sionna Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 6.90 · gapped above the open, then crossed back over prior close. High/low 8.20 at 5:15 am ET, 6.89 at 4:00 pm ET.
SION (Sionna Therapeutics, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: SNY −2.03%, in industrials & materials.